Atypical femoral fractures bilaterally in a patient receiving denosumab. [electronic resource]
Producer: 20140414Description: 3-5 p. digitalISSN:- 1745-3682
- Aged
- Alendronate -- adverse effects
- Antibodies, Monoclonal, Humanized -- administration & dosage
- Bone Density Conservation Agents -- administration & dosage
- Denosumab
- Drug Administration Schedule
- Female
- Femoral Fractures -- chemically induced
- Fractures, Stress -- chemically induced
- Humans
- Osteoporosis, Postmenopausal -- drug therapy
- Osteoporotic Fractures -- prevention & control
- Radiography
No physical items for this record
Publication Type: Case Reports; Journal Article
There are no comments on this title.
Log in to your account to post a comment.